News

Former Leafs posted the news Sunday evening. Kirton, 67, was diagnosed with amyotrophic lateral sclerosis, or Lou Gehrig’s ...
Medically reviewed by Nicholas R. Metrus, MD Multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS, also called Lou Gehrig's disease) are both diseases that affect your central nervous system ...
Developing approved therapies for ALS has been painfully slow, as evidenced by the failure of more than 95 per cent of ALS ...
A Jacksonville woman's experience caring for her husband with ALS has formed a foundation to help other families fighting terminal illness.
I have ALS, also known as amyotrophic lateral sclerosis or Lou Gehrig’s disease. Named for the famous baseball player, it’s a neuro-degenerative disorder. But I’m not here to discuss the ...
The rousing biographical drama centred on one of the most renowned figures in science will be leaving Netflix on August 16.
BCLI READ THE FULL BCLI RESEARCH REPORT Business Update Focused on Advancing NurOwn into Phase 3b ENDURANCE Trial BrainStorm ...
SNUG01 showed favorable safety and signs of early clinical efficacy in a recently completed investigator-initiated trial in China, the firm said.
SineuGene Therapeutics Co., Ltd. ("SineuGene"), clinical-stage biotechnology company that mainly focuses on gene therapies for neurological disorders, announced today that China's National Medical ...
Earnings per share (GAAP) was $0.13 for Q2 2025, outperforming GAAP estimates for a loss of $0.23. Net loss (GAAP) fell to $11.2 million for Q2 2025, due to a significant gain from changes in warrant ...
Clene (NASDAQ: CLNN) , a late clinical-stage biopharma company developing treatments for neurodegenerative diseases, reported Q2 2025 results and sai ...
Four volunteers with paralysis manage to communicate thanks to a brain reader that only activates when they think of the ...